Quantcast

Latest Topical Stories

2014-07-18 08:24:41

BUENA, N.J., July 18, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced the Company will hold a conference call at 4:15 pm ET on Thursday, July 24, 2014 to discuss the 2nd quarter 2014 results. http://photos.prnewswire.com/prnvar/20130827/MM70487LOGO The Company invites you to listen to the call by dialing 1-877-870-4263. International participants should call 1-412-317-0790. Canadian...

2014-07-17 08:29:14

NEW YORK, July 17, 2014 /PRNewswire/ -- Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) today announced successful completion and initial results of DPX-110, a Phase 1 skin irritation clinical trial of Locilex® (pexiganan cream 0.8%), the company's novel, broad-spectrum topical antibiotic peptide. Dipexium conducted DPX-110 and the company is conducting DPX-120, a Phase 1 skin sensitization clinical trial, in parallel with two required pivotal Phase 3 clinical trials for Locilex®....

2014-07-09 08:28:37

EpiCeram(R) Controlled Release Skin Barrier Emulsion now offers dosing flexibility with 2 sizes SOUTH PLAINFIELD, N.J., July 9, 2014 /PRNewswire/ -- PuraCap(TM) Pharmaceutical today announced the newest addition to the EpiCeram(R) product line, the EpiCeram(R) 225g Airless Pump. The unique airless pump gives patients more EpiCeram(R) to treat any size area of atopic dermatitis. The special dispensing system allows for more control, delivering EpiCeram(R) consistently and precisely...

2014-06-26 08:28:38

BUENA, N.J., June 26, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced that it has entered into an agreement with Mallinckrodt LLC, Mallinckrodt Inc., and Nuvo Research, Inc. (TSX: NRI) (together Mallickrodt) to settle a declaratory judgment action brought by IGI, concerning IGI's filing of an abbreviated new drug application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to...

2014-06-23 12:25:16

SARASOTA, Fla., June 23, 2014 /PRNewswire/ -- Biolife LLC today announced that its WoundSeal topical powder, a consumer product that stops bleeding instantly, has cumulatively sold through more than 4 million applications across the United States as of June 1, 2014. WoundSeal stops minor external bleeding through the creation of an instant scab (or seal) once the powder combines with the wound's own blood. http://photos.prnewswire.com/prnvar/20140620/119703 "The response from...

2014-05-08 23:16:22

ithriveX, all natural, long lasting joint and muscle cream made its debut at Nashville's annual Music City Marathon event on Saturday, April 26, 2014. Sports mom of four, Lisa Allain, developed ithrivex as a suitable, more natural and effective alternative to pills and topical painkillers with chemicals and synthetic ingredients. Nashville, Tennessee (PRWEB) May 08, 2014 ithriveX, all natural, long lasting joint and muscle cream made its debut at Nashville’s annual Music City...

2014-05-04 23:00:50

ReportsnReports.com adds “Transdermal Drug Delivery Market & Clinical Pipeline Insight” report to its research database. Dallas, Texas (PRWEB) May 04, 2014 Transdermal drug delivery system, over the past decades, has emerged as a major tool for treating diseases of the skin. The major underlying factor driving this method is that the human skin is the most readily accessible surface for the delivery of drugs. A transdermal patch is defined as a medicated adhesive patch which is...

2014-04-29 08:36:10

Requests Court Confirmation that PerClot Does Not Infringe Bard Patent ATLANTA, April 29, 2014 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has received 510(k) clearance for PerClot Topical hemostatic powder from the U.S. Food and Drug Administration (FDA). This clearance allows CryoLife to begin commercialization of PerClot Topical hemostatic powder in the U.S....

2014-04-23 08:31:25

MISSISSAUGA, ON, April 23, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced a collaboration involving Ferndale Laboratories, Inc. (Ferndale) and a leading Contract Research Organization (CRO) with significant dermatology experience to develop two topical dermatology products based on Nuvo's patented Multiplexed Molecular Penetration Enhancer (MMPE(TM)) technology. "This...

2014-04-22 08:33:05

BUENA, N.J., April 22, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced the Company will hold a conference call at 4:30 pm ET on Tuesday, April 29, 2014 to discuss the 1st quarter 2014 results. http://photos.prnewswire.com/prnvar/20130827/MM70487LOGO The Company invites you to listen to the call by dialing 1-866-515-2913. International participants should call 1-617-399-5127. The...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related